Vanadium in patients undergoing chronic haemodialysis.
The relationships between serum vanadium and serum aluminium, beta 2-microglobulin, silicon, phosphate, red blood cell count, haemoglobin and systolic blood pressure were studied in 80 chronic haemodialysis patients. Vanadium transfer during haemodialysis was also examined. Serum vanadium in 80 patients before haemodialysis was 18.4 +/- 7.6 ng/ml (normal values: 0.4 +/- 0.2 ng/ml). Significant correlations between serum vanadium and serum aluminium, silicon, beta 2-microglobulin, phosphate, red blood cell count, haemoglobin, and systolic blood pressure were found. As ultrafiltrate vanadium was greater than vanadium in the dialysate, vanadium transfers from blood to dialysate. Therefore, serum vanadium before haemodialysis significantly decreased from 18.4 +/- 7.76 ng/ml to 13.0 +/- 5.30 ng/ml, during a 5-h haemodialysis.
Hosokawa
S
S
Utano National Hospital, Kyoto, Japan.
Yoshida
O
O
D000535:Aluminum / Q000097:blood; D001794:Blood Pressure; D002118:Calcium / Q000097:blood; D004906:Erythrocyte Count; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects; D012825:Silicon / Q000097:blood; D014639:Vanadium / Q000097:blood*; D001613:beta 2-Microglobulin / Q000378:metabolism
D006454:Hemoglobins; D010710:Phosphates; D001613:beta 2-Microglobulin; D014639:Vanadium; D000535:Aluminum; D002118:Calcium; D012825:Silicon